Search bioRxiv⌕ Search

Biology subjects

LOYER, P.

Publications and source records attributed to LOYER, P..

2 recordsLinked to original sources

Isolation of rat and human hepatic cholangiocytes using a peptide derived from a conserved domain of enterobacteria BamA/TamA-like proteins

Using the phage display technology, we identified a novel peptide, P11Chol, which preferentially binds to both human and rat cholangiocytes. Peptide P11Chol alignment with protein databases evidenced strong similarities with a highly conserved peptide motif from BamA/TamA-like outer membrane proteins expressed in enterobacteriaceae belonging to Pseudomonadota phylum including Photorhabdus, Providencia, Acinetobacter, Salmonella enterica and Helicobacter pylori species. In addition, we showed that Providencia stuartii bacteria were able to bind to cholangiocytes-like HepaRG cells in vitro and that P11Chol modulated this interaction suggesting the possible involvement of BamA/TamA-like outer membrane proteins in cell adhesion and/or internalization of Providencia stuartii bacteria. Using fluorescent P11Chol peptide, we next developed a flow cytometry procedure to detect and isolate rat and human liver epithelial cells from hepatic cell suspension obtained after collagenase dissociation of liver parenchyma. Three distinct P11Chol-positive rat liver epithelial cell lines (RLEC) were established, which produced functional cholangiocytes capable to form cyst-like structures in vitro and to maintain expression of specific functions in hepatocytes in coculture. The characterization of these three RLEC lines evidenced functional differences that support the concept of small and large cholangiocytes exhibiting different functional phenotypes within the intrahepatic bile tree.

cell biology↗

Efficient internalization of poly(benzyl malate) and poly(ethylene glycol)-b-poly(benzyl malate) copolymer based nanoparticles by human hepatic HepaRG cells and macrophages : Impact of nanoparticle functionalization by GBVA10-9 peptide on cell uptake.

In the past years, we have designed biodegradable poly(benzyl malate) (PMLABe73) homopolymer and amphiphilic poly(ethylene glycol)-b-PMLABe (PEG42-b-PMLABe73) copolymer and several modified (co)polymers to produce biocompatible polymeric nanoparticles (NPs) capable of targeting hepatic cells in vitro with the goal to develop applications in the treatment of liver diseases. The current study aimed at comparing the uptake of PMLABe73 PEG42-b-PMLABe73-based NPs in human hepatic HepaRG cells, primary macrophages and peripheral blood mononuclear cells (PBMC). The uptake of NPs prepared from PEG42-b-PMLABe73 was significantly lower than that of PMLABe73 in both hepatic cells and macrophages. In addition, the NPs uptake by HepaRG cells was inversely correlated to the density of PEG present on their surface. In contrast, the internalization of with PMLABe-based NPs by human macrophages was not affected by low PEG densities, only uptake of fully pegylated PEG42-b-PMLABe73based-NPs was significantly decreased. Herein, we also showed that PMLABe-based NPs did not strongly accumulated in PBMC, T lymphocytes and neutrophils while monocytes showed slightly higher uptake of these NPs. Moreover, we further demonstrated that PMLABe-derived NPs by did not trigger inflammasome activation and secretion of pro-inflammatory cytokines neither in macrophages nor HepaRG cells. Then, we demonstrated that peptide GBVA10-9 derived from George Baker (GB) Virus A, known to exhibit a good hepatotropism did not significantly affect the uptake of PMLABe73-based NPs in HepaRG cells and macrophages, when grafted onto these NPs. The present results demonstrate that PMLABe-derived NPs are very efficiently internalized in both macrophages and hepatocytes but not in PBMC and reinforce our previous reports regarding their biocompatibility.

cell biology↗